Mortality Characteristics due to TB/HIV coinfection and problems identified in units of analysis, Colombia, 2018.
DOI:
https://doi.org/10.33610/01229907.2019v1n2a2Keywords:
HIV, Mortality, Risk factors, Problem categories, Units of analysis, TB/HIV coinfectionAbstract
Introduction: the risk of developing tuberculosis (TB) in the population with HIV is 20 times higher than in the rest of the general population. For 2018, the coinfection burden was 9.3 %, of which a significant number of deaths caused by co-infection were recorded.
Objective: to describe the characteristics of TB/HIV mortality in 2018, and identify gaps in the comprehensive care of co-infected cases under or equal to 49 years of age.
Methodology: a retrospective descriptive study based on the notification of cases of tuberculosis with TB/HIV coinfection that entered Sivigila and the Unified Registry of Affiliates, selecting records that had tuberculosis and HIV as simultaneous causes, from which a problem analysis was performed according to units of analysis.
Results: 1 300 TB deaths were identified among HIV-negative persons and 278 TB deaths among HIV-positive persons. The male-to-male ratio was 3,4. The groups most affected were those aged 35 to 39 years (21,8 %), followed by those aged 40 to 44 (21,4 %), with the pulmonary form accounting for the largest number of cases (77,7 %) and the extrapulmonary form (22,3 %), with the meningeal localization being the most frequent (54,6 %). The categories of problems identified were: service provision (35,6 %); induced demand and specific protection (29,2 %); territorial management (9,6 %); insurance (13,4 %); risk perception and environment (12,2 %); among others.
Conclusions: mortality due to TB/HIV coinfection mainly affects young men, which requires sectoral and intersectoral actions to impact the problems identified.
References
World Health Organization. Global tuberculosis report 2019. Geneva: World
Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.
López-Pérez MP. Informe de evento de tuberculosis. Colombia, 2018 [Internet]. Colombia: Instituto Nacional de Salud; 2019. 29 p. Disponible en: https://www.ins.gov.co/buscadoreventos/Informesdeevento/TUBERCULOSIS_2018.
Ministerio de Salud y Protección Social. Plan Estratégico “Hacia el fin de la Tuberculosis” 2016- 2025. Colombia: Ministerio de Salud, Organización Panamericana de Salud; 2016 sept.
Montufar FE, Villa P, Montúfar M, Zuleta J, Pérez LE, Monsalve MA, et. al. Coinfección por virus de inmunodeficiencia humana y micobacterias en un hospital universitario de alta complejidad en Colombia. Infect.2016;20(3):158-164. https:// doi.org/10.1016/j.infect.2015.05.006.
Sperli ML, Zanon MA, Figueiredo SH, Scatena TC, Sperli N, Domingues A, et. al. La dimensión epidemiológica de la coinfección TB/VIH. Rev Latino-am Enfermagem. 2009; 17(5). Disponible en: www.eerp.usp.br/rlae.
Mendoza A, Iglesias David. Tuberculosis en pacientes con VIH/SIDA. Acta méd. Peruana [Internet]. 2008; 25(4): 247 - 254. ISSN 1728-5917.
Villa L, Trompa IM, Montes FN, Gómez JG, Restrepo CA. Análisis de la mortalidad por tuberculosis en Medellín, 2012. Biomédica. 2014; 34: 425-32. http://dx.doi.org/10.7705/biomedica.v34i3.2336.
Onyango DO, Yuen CM, Cain KP, Ngari F, Masini EO, Borgdorff MW. Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya. PLoS ONE. 2017 nov. 16; 12(11): e0188235. doi: 10.1371/ journal.pone.0188235.
Guerra J, Mogollón D, González D, Sánchez R, Rueda ZV, Parra-López CA, et. al. Active and latent tuberculosis among inmates in La Esperanza prison in Guaduas, Colombia. PLoS One. 2019; 14(1): e0209895. doi: 10.1371/journal. pone.0209895.
Surkova LK, Dius’mikeeva MI, Puchkov AF. Errors in the diagnosis of tuberculosis in general hospitals. Klin Med (Mosk). 1991 sept.; 69(9): 40-3.
Bologna R. Enfoques metodológicos, Tuberculosis infantil, Tuberculosis en las Américas. Rev del hospital de pediatría de Garrahan. 2018; 25(4): 331-334. http://www.medicinainfantil.org.ar
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Reporte Epidemiológico Nacional
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
